Main content

    Hepatology Publications

    Our hepatologists at California Pacific Medical Center's San Francisco Center for Liver Disease are active in hepatology research. Accordingly, they have contributed to or led research efforts surrounding hepatology topics such as hepatitis B, hepatitis C, acute liver failure and drug-induced liver injury.

    CPMC Hepatology Publications

    See our physicians' published hepatology researchOpens new window

    Recent CPMC Hepatology Publicatications

    1. Davern TJ. Drug-induced liver disease. Clin Liver Dis. 2012 May;16(2):231-45.Opens new window
    2. Holt EW, Frederick RT, Verhille MS. Prognostic Value of Muscle Wasting in Cirrhotic Patients. Clin Gastroenterol Hepatol. 2012 Apr 10Opens new window

    3. Frederick RT. Extent of reversibility of hepatic encephalopathy following
      liver transplantation. Clin Liver Dis. 2012 Feb;16(1):147-58Opens new window

    4. Singh KM, Phung YT, Kohla MS, Lan BY, Chan S, Suen DL, Murad S, Rheault S, Davidson P, Evans J, Singh M, Dohil S, Osorio RW, Wakil AE, Page K, Feng S, Cooper SL. KIR genotypic diversity can track ancestries in heterogeneous populations: a potential confounder for disease association studies. Immunogenetics. 2012 Feb;64(2):97-109.Opens new window


    5. Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, Engle RE, Nguyen H, Emerson SU, Purcell RH, Tillmann HL, Gu J, Serrano J, Hoofnagle JH; Drug-Induced Liver Injury Network (DILIN). Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology. 2011 Nov;141(5):1665-72Opens new window

    6. Frederick RT. Current concepts in the pathophysiology and management of hepatic encephalopathy. Gastroenterol Hepatol (N Y). 2011 Apr;7(4):222-33Opens new window

    7. Gish RG, Cooper SL. Hepatitis B in the Greater San Francisco Bay Area: an integrated programme to respond to a diverse local epidemic. J Viral Hepat. 2011 Apr;18(4):e40-51.Opens new window

    8. Publicover J, Goodsell A, Nishimura S, Vilarinho S, Wang ZE, Avanesyan L, Spolski R, Leonard WJ, Cooper S, Baron JL. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J Clin Invest. 2011 Mar;121(3):1154-62.